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Background: Experimental and human studies have demonstrated that innate immune mechanisms and
consequent inflammatory reaction play a critical role in cardiac response to ischemic injury. Thus, the detection of
immuno-inflammatory and cellular phenomena accompanying cardiac alterations during the early inflammatory
phase of myocardial infarction (MI) may be an excellent diagnostic tool. Current knowledge of the chronology of
the responses of myocardial tissue following the occurrence of ischemic insult, as well as the existence of numerous
studies aiming to identify reliable markers in dating MI, induced us to investigate the myocardial specimens of MI
fatal cases in order to better define the age of MI.
Methods: We performed an immunohistochemical study and a Western blot analysis to evaluate detectable
morphological changes in myocardial specimens of fatal MI cases and to quantify the effects of cardiac expression
of inflammatory mediators (CD15, IL-1β, IL-6, TNF-α, IL-15, IL-8, MCP-1, ICAM-1, CD18, tryptase) and structural and
functional cardiac proteins.
Results: We observed a biphasic course of MCP-1: it was strongly expressed in the very early phase (0-4 hrs), to
diminish in the early period (after 6-8 hrs). Again, our choice of IL-15 is explained by the synergism with neutrophilic
granulocytes (CD15) and our study shows the potential for striking cytokine synergy in promoting fast, local neutrophil
response in damaged tissues. A progressively stronger immunoreaction for the CD15 antibody was visible in the areas
where the margination of circulating inflammatory cells was detectable, up to very strong expression in the oldest ones
(>12 hours). Further, the induction of CD15, IL-15, MCP-1 expression levels was quantified by Western blot analysis. The
results were as follows: IL-15/β-actin 0.80, CD15/β-actin 0.30, and MCP-1/β-actin 0.60, matching perfectly with the
results of immunohistochemistry. Control hearts from traumatic death cases did not show any immunoreactivity to
the pro-inflammatory markers, neither were there any reactions in Western blot analysis.
Conclusions: Essential markers (i.e. IL-15, MCP-1) are suitable indicators of myocardial response to ischemic insult
involving very early phase reaction (inflammatory response and cytokine release). In the very near future, proteomics
may help clinicians and pathologists to better understand mechanisms relating to cardiac repair and remodeling and
provide targets for future therapies.
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From a clinical point of view, the term myocardial in-
farction (MI) can be used when there is evidence of
myocardial necrosis in a clinical setting consistent with
acute myocardial ischemia. Clinical features include
electrocardiographic findings and elevated values of
biochemical markers of myocardial necrosis [1]. From
a pathological point of view, MI consists in a particular
myocardial cell death due to ischemia. After the onset
of myocardial ischemia, cell death is not immediate,
but takes a finite period of time to develop. Complete
myocytes necrosis is followed by a process leading to
healed infarction. The symptoms and signs of MI may
be confusing, and only rarely can this assessment be
solved on the basis of clinical data [1].
Experimental and human studies have demonstrated
that innate immune mechanisms and consequent inflam-
matory reaction play a critical role in cardiac response to
ischemic injury (Figure 1) [2-6]. Thus, the detection of
immuno-inflammatory and cellular phenomena accom-
panying the cardiac alterations during early inflammatoryFigure 1 The time course of the inflammation, repair, and remodelingphase of MI may be an excellent diagnostic tool. Before
the influx of inflammatory cells becomes histologically de-
tectable, the presence and nature of cellular and humoral
mediators can be evaluated by immunohistochemistry. At-
tention should be focused on the immunohistochemical
detection of different markers of myocardial response to
ischemic insult. Humoral and cellular mediators have
proved a worthwhile target for the postmortem diagnosis
and timing of ischemia-induced cardiac injury [7-15].
Current knowledge of the chronology of the responses
of myocardial tissue following the occurrence of ische-
mic insult, as well as the existence of numerous studies
aiming to identify reliable markers in dating MI,
induced us to investigate the myocardial specimens of
MI fatal cases in order to better define the age of MI
[16-18].
We performed an immunohistochemical study and a
Western blot analysis to evaluate detectable morpho-
logical changes in myocardial specimens of fatal MI cases
and to quantify the effects of cardiac expression of inflam-
matory mediators (CD15, IL-1β, IL-6, TNF-α, IL-15, IL-8,of the infarcted heart.
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functional cardiac proteins (troponin I and troponin C).
Methods
Clinical data and tissue specimens
The clinical data and autopsy records of the 1260 autop-
sies performed at the Departments of Forensic Pathology
of the University of Foggia and the University of Pisa
(Italy) over the period 2001–2013 were evaluated, and 26
cases in which MI was indicated as cause of death were
selected. We selected only cases with a well-defined clin-
ical course (clinical symptoms, ECG and laboratory data),
and in which postmortem examination confirmed the
diagnosis of MI. The patients had a survival time ranging
from 4–6 hours to more than 12 hours from the abrupt
onset of typical symptoms. Twenty-five cases of instant
death or with survival limited to 12 hours due to injuries
from firearms without pathological cardiac involvement,
were selected as the control group. In each case, the tissue
samples obtained from the heart (standard seven speci-
mens and additional samples taken from areas with
macroscopic alterations, stained by hematoxylin–eosin
and trichromic stains) were re-examined histologically.
In addition, an immunohistochemical investigation of
all the samples was performed utilizing a panel of anti-
bodies (CD15, DAKO, Copenhagen, Denmark), IL-1β
(Santa Cruz, CA, USA), IL-6 (Santa Cruz, CA, USA),
TNF-α (Santa Cruz, CA, USA), IL-15 (R&D Systems,
Minneapolis, MN, USA), IL-8 (Abcam, Cambridge,
UK), MCP-1 (Santa Cruz, CA, USA), ICAM-1 (Santa
Cruz, CA, USA), CD18 (Abcam, Cambridge, UK), tryp-
tase (Novus Biologicals, Littleton, CO, USA). To obtain
a better definition of early infarction, we matched the
samples with very early markers of necrosis such as
cellular antigen troponin C (Novocastra Leica Biosystems
GmbH, Nussloch, Germany) and Troponin I (Thermo
Fisher Scientific, Fremont, CA, USA). We used 4 mm-thick
paraffin sections mounted on slides covered with 3-
amminopropyl-triethoxysilane (Fluka, Buchs, Switzerland).
Pre-treatment was necessary to facilitate antigen retrieval
and to increase membrane permeability to antibodies anti-
CD 15, IL-1β, MCP-1, IL-15, ICAM-1, CD 18, IL-8, tropo-
nin C and troponin I boiling in 0.25 M EDTA buffer, to
antibodies anti-TNF-α boiling in 0.1 M Citric Acid buffer,
to antibody anti- IL-6 and tryptase for 15 min. in Proteo-
lytic Enzyme (Dako, Copenhagen, Denmark), at 20°C.
The primary antibody was applied in a 1:50 ratio CD
15, in a 1:4000 ratio IL-1β, in a 1:2000 ratio IL-6, in a
1:600 ratio TNF-α, in a 1:100 ratio IL-15, in a 1:500 ratio
IL-8, ICAM-1 and MCP-1, in a 1:1000 ratio tryptase, in
a 1:200 ratio CD 18, in a 1:3000 ratio troponin I and in a
1:6000 ratio troponin C and incubated for 120 min at
20°C. The detection system utilized was the LSAB + kit
(Dako, Copenhagen, Denmark), a refined avidin–biotintechnique in which a biotinylated secondary antibody
reacts with several peroxidase conjugated streptavidin
molecules. The positive reaction was visualized by 3.3-
diaminobenzidine (DAB) peroxidation, according to
standard methods. The sections were counterstained
with Mayer’s haematoxylin, dehydrated, coverslipped
and observed in a Leica DM4000B optical microscope
(Leica, Cambridge, UK). A semi-quantitative evaluation of
the immunohistochemical findings was made by two
different investigators without prior knowledge. The re-
actions were graded as follows: 1. (0): not expressed, 2.
(+): isolated and disseminated expression, 3. (++): ex-
pression in widespread foci, 4. (+++): widespread ex-
pression. All measurements were carried out using the
same magnification of image (10×) and by the same two
examiners. A third blind microscopic evaluator was in-
volved to weigh the histological evidence. The samples
were also examined under a confocal microscope, and a
three-dimensional reconstruction was performed (True
Confocal Scanner, Leica Biosystems GmbH TCS SPE).
Western blot analysis
Western blot analysis was performed. Approximately
100 mg of frozen cardiac tissue was dissected and imme-
diately transferred to the RIPA buffer with a protease in-
hibitor cocktail, and homogenized on ice utilizing the
homogenizer Silent Crusher. The homogenate was cen-
trifuged (12000 RPM for 10 min at 4°C). The super-
natant was collected, estimated by Qubit Fluorometer
(Invitrogen), and boiled for 5 min, at 95°C. Cardiac total
protein extracts (approximately 40 μg/lane) were run on
4-15% SDS PAGE at 80 V for about 2.5 hr. For Western
blot, proteins from SDS (sodium dodecyl sulfate) gels were
electrophoretically transferred to nitrocellulose membranes
in mini trans blot apparatus (1 hr at 250 mA). Non-specific
binding was blocked by incubating membranes in Western
blocker solution for 1 hr at room temperature. The
membranes were incubated with primary antibodies
anti-TNF- α, IL-1β, IL-6, IL-8, MCP-1, CD 18, IL-15,
CD 15, Tryptase, ICAM-1diluted in Western blocker so-
lution, in 1:400 ratio for TNF-α, in 1:200 ratio for IL-1β,
IL-15, CD 15, IL-6, IL-8, MCP-1, CD 18, Tryptase,
ICAM-1 overnight at 4°C. Blots were washed with PBS
(Phosphate Buffered Saline/Tween-20) and then incubated
for 1 hr at room temperature with HRP (horseradish
peroxidase)-conjugated secondary antibodies diluted in
Western blocker solution, in a 1:2000 ratio. Membranes
were washed with PBS/Tween-20, and the immune re-
action was developed in IMMUNOSTAR Kit Western C
(Bio-Rad laboratories) and then visualized by Chemilumin-
escent detection methods. The light was then detected by
photographic film. The image was analyzed by Versadoc
(Bio-Rad laboratories), which detected the chemilumines-
cent blots of protein staining.
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A semi-quantitative evaluation of the immunohistochemi-
cal findings and gradation of the immunohistochemical
reaction were described with an ordinal scale and the
median value reported. An analysis of variance for the
non-parametric data between groups was performed
using the Kruskal-Wallis test. When differences were
found to be significant, an analysis between the unmatched
groups was performed with a Dunn's Multiple Comparison
post hoc test. Significance level was set to 5% (SPSS ver.
16.01 for Windows - SPSS Inc., Chicago USA).
Results
Clinical data and histological results were compared to
assemble the MI cases in chronological homogenous
groups. The microscopic observation of myocardial
samples showed the following chronological differ-
ences of the myocardium. In the group of very early
MI (approximately 0–6 hours from the onset of ische-
mia related symptoms), mild myofiber eosinophilia and
elongation of sarcomeres and nuclei were fairly evident
(loss of contraction/atonic death of myofibers) as well as
prominent contraction band necrosis. No histological
signs of polimorphonuclear margination (PMN) were vis-
ible. In the same cases an immunohistochemical investiga-
tion revealed a mild positivity of CD15, tryptase, IL-1β,
IL-6, TNF-α, IL-8, CD18, ICAM-1 and intense IL-15 and
MCP-1 reactions in the infarcted zone matched by the
immunodepletion of negative markers of necrosis (cellular
antigen troponin) (Figure 2).
In the group of early infarction (approximately 6–8
hours from the onset of ischemic symptoms and signs)
margination of PMN leukocytes that include neutrophils
and monocytes was detectable in vessels at the periphery of
the necrotic zone along with infiltration of these elements
into the ischemic issue. A crowd of PMN was visible
along a line between infiltrated and non-infiltrated nec-
rotic myocardium in large areas of necrosis. Immunohis-
tochemistry confirmed the nature of the inflammatory
cells. A progressively stronger immunoreaction for the
CD15 antibody was visible in the areas where the margin-
ation of circulating inflammatory cells was detectable up
to very strong expression in the oldest ones (>12 hours)
(Figure 3) (Table 1).
Further, the induction of CD15, IL-15, MCP-1 expres-
sion levels was quantified by Western blot analysis. The
results were as follows: IL-15/β-actin 0.80, CD15/β-actin
0.30, and MCP-1/β-actin 0.60, matching perfectly with
the immunohistochemistry results (Figure 4). Control
hearts from traumatic death cases did not show any
immunoreactivity to the pro-inflammatory markers, neither
were there any reactions in Western blot analysis.
These two chronological groups are homogenous
and the described morphological changes were classifiedwhen clinical data coherently supported the microscopic
chronological modification.
Our results are summarized in Table 2 with possible
classification based on histological, immunohistochemical
age determination and western blotting quantification of
MI.
Discussion
Our data show that some investigated parameters,
such as CD15, IL-15, MCP-1, have a significantly dif-
ferent expression in the groups being studied (very
early and older infarction). Monocyte chemotactic pro-
tein (MCP)-1, expressed by the main inflammatory and
stromal cells, such as endothelial cells, mediates the re-
cruitment of mononuclear cells, modulates monocyte
and lymphocyte phenotype and regulates fibrous tissue
deposition and angiogenesis. Its expression is upregu-
lated after proinflammatory stimuli and tissue injury
[19]. We observed a biphasic course of MCP-1: it was
strongly expressed in the very early phase (0-4 hrs),
diminishing in the early period (after 6-8 hrs). Again,
our choice of IL-15 is explained by the synergism with
neutrophilic granulocytes (CD15) and our study shows
the potential for striking cytokine synergy in promoting
fast, local neutrophil response in damaged tissues. Neutro-
phils are major players in inflammation and are known to
express all components of the IL-15.
It is well known that the response of the myocardium
to ischemic insult can be divided into overlapping
phases: the inflammatory phase, the proliferative phase
and the maturation phase. Sudden induction of ischemia
triggers a series of events that culminate in the death of
ischemic cardiomyocytes; the necrotic muscle elicits an
inflammatory cascade that serves to clear the infarct
from dead cells and matrix debris, and ultimately results
in the healing and replacement of the damaged tissue
with scarring [3,20].
The pathological pictures of the later stages (i.e. pro-
liferative and maturation) are quite well-known: start-
ing from 2–3 weeks from MI, pronounced peripheral
granulation tissue with sprouted capillary blood vessels,
fibrocytes, fibroblasts, lymphocytes, some plasma cells,
macrophages, possibly siderophages, and some granu-
locytes become increasingly apparent. From 5 weeks to
2–3 months, histological findings included collagen
fiber or scar tissue with endothelially-coated blood ves-
sels of varying density, siderophages still possible,
loose infiltration with lymphocytes, very few plasma
cells, and scant granulocytes [21-23]. In the inflamma-
tory phase, immediately following myocardial ische-
mia, chemokines and cytokines are induced in the
infarct and marked leukocyte infiltration is noted.
Neutrophils and macrophages clear the wound from
dead cells and matrix debris.
Figure 3 Time course of cytokines and extracellular matrix protein up-regulation in myocardial infarcts at 6-12hs. (A) Little foci of
myocardial necrosis (<6 h) with intravasal and interstitial CD15 reaction (brown reaction); (B) Double immunohistochemical reaction (IL-15 and
CD15): foci of myocardial necrosis (>6 h) with intensive expression of IL-15 and CD15. (C) Double immunohistochemical reaction (MCP-1 and
CD15) showed a diffuse positivity (red and yellow respectively) after 6 hrs. (D) CD15 reaction after 6 hrs, after 8 hrs, after 10 hrs, and 12 hrs.
Figure 2 Time course of cytokine and extracellular matrix protein up-regulation in myocardial infarcts at 4hs. (A) Troponin I is markedly
unexpressed in a large area of infarcted myocardium (Ab-anti TnI). (B) The confocal microscopic observation of early (4hs) myocardial infarction
showed a large area of TnC depletion (in green the TnC reaction). (C) Double immunohistochemical reaction (IL-15 and CD15) evidenced an
intense IL-15 (bleu) and sporadic CD15 (white) reactions in the infarcted zone. (D) Double immunohistochemical reaction (MCP-1 and CD15):
MCP-1 reaction (red) is intense as well as CD15 (yellow) in the infarcted zone after 4 hrs.
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Table 1 Semi-quantitative evaluation and statistical analysis of the immunohistochemical findings and gradation of
the immunohistochemical reaction in the heart samples
Antibody Group A (≤4-6 hours from the
onset of ischemia related symptoms)
Group B (≥6-8 hours from the onset
of ischemic symptoms and signs)
Group C
controls
Significant level Significance levels1
CD15 + +++ - A vs C **
B vs C ***
A vs B **
IL-1β + +++ − A vs C **
B vs C ***
A vs B **
IL-6 + +++ - A vs C **
B vs C ***
A vs B **
TNF-α + +++ - A vs C **
B vs C ***
A vs B **
IL-15 +++ + − A vs C ***
B vs C **
A vs B **
IL-8 ++ +++ − A vs C **
B vs C ***
A vs B *
MCP-1 +++ + - A vs C ***
B vs C **
A vs B **
ICAM-1 + ++ − A vs C *
B vs C **
A vs B *
CD18 - - − A vs C ns
B vs C ns
A vs B ns
Troponin C + +++ _ A vs C **
B vs C ***
A vs B **
Troponin I + +++ _ A vs C **
B vs C ***
A vs B **
Tryptase + +++ − A vs C **
B vs C ***
A vs B **
1Intensity of immunopositivity was assessed semiquantitatively in the scale 0–4 as follows: 1. (0): not expressed, 2. (+): isolated and disseminated expression,
3. (++): expression in widespread foci, 4. (+++): widespread expression.
NS: p > 0.05; *: p < 0.05; **: p < 0.01; ***: p < 0.001.
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underlying the very early phase of myocardial response
to ischemia are well known [3,5], on the other hand, the
weakest part of the available morphological evidence todate appears to be right in this phase when cellular reaction
is not yet histologically detectable.
The finding of IL-15, MCP-1 expressions in the car-
diac specimens of early infarction confirm a considerable
Figure 4 Western blot analysis. (A) Immunoblot analysis demonstrated the presence of IL-15, with a molecular weight of approximately 15 kDa,
obtained from the cardiac tissue and the graphic overview of results based on the light intensity and the number of pixels detected, which shows a
quantified intensity at 4 hours. (B) Immunoblot analysis demonstrated the presence of MCP-1, with a molecular weight of approximately 12 kDa,
obtained from the cardiac tissue. A graphic overview of results based on the light intensity and the number of pixels detected, showing the
concentration at 4 hours.
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(cytokines and inducible chemokines, complement, and
toll-like receptors) and cellular (monocytes, macrophages,
dendritic cells, T cells, mast cells, platelets, endothelial
cells) mediators in the initial healing phases following car-
diomyocytes death [4,6,17,24-31]. Activation of cytokine
cascades in the infarcted myocardium was establishedTable 2 Histological/immunohistochemical and Western blott
Cell death Up to 30 minutes – 1 hour
Inflammatory phase 4-6 hours
6-8 hoursin numerous studies. In experimental models of myo-
cardial infarction, the induction and release of the pro-
inflammatory cytokines are regularly described [16,17].
The multifunctional, overlapping and often contradictory
effects of the cytokines have hindered understanding of
their functional role in cardiac injury and repair. In the in-
farcted area, a marked cytokine up regulation is presenting age determination of MI
Cytoplasm and mitochondrial swelling and dissolution of the cristae
mitochondriales (electron microscopy); loss of contraction with
stretching of the myocardium in flaccid paralysis, resulting in a very
early elongation of sarcomeres and nuclei; mild myofiber eosinophilia.
Foci of contraction band necrosis. At immunohistochemistry loss of
cellular antigen (myoglobin and cardiac troponin) is detectable earlier
than the accumulation of plasma markers (C5b-9 complex, fibronectin).
Mild positivity of immunoreaction (tryptase, CD15, IL-1β, IL-6, IL-8, TNF-α)
and stronger reactivity for IL-15, MCP-1 in areas where depletion of cellular
antigens (myoglobin and cardiac troponin) is detectable within 30 – 40
minutes from ischemia.
Necrosis of the infarcted area becomes more evident; a crowd of
polymorphonuclear leukocyte infiltration from the periphery is evident.
General and intense eosinophilia of myofibers. Interstitial oedema.
Immunopositivity to the antibodies anti tryptase, CD15, IL-1β, IL-6, IL-8,
IL-15, TNF-α becomes stronger and ubiquitously widespread. MCP-1
decrease as intensity in respect to the first hours.
Pronounced necrosis of the infarcted areas; strong evidence of PMN
margination with further leukocyte penetration of the infarct area. Strong
immunopositivity to anti CD15 antibodies was observed.
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(ROS) generation, complement activation, and NF-κB
(nuclear factor kappa-light-chain-enhancer of activated
B cells) activation potently stimulate cytokine mRNA
(Messenger Ribonucleic acid) synthesis in both resident
and blood-derived cells [16-18].
Many authors have attempted to assess the histological
age of MI, classifying the chronological phenomena into
phases using histochemical methods only. The first at-
tempts were established by White et al. [32] who graded
“the speed of healing” as follows: [1, represents the reac-
tion and death of the heart muscle cells as the result of
the blocking of the blood supply during the first 24 to
48 hours before the appearance of many invading cells;
2, the invasion by multitudes of white cells which come
to clear away the debris of the very necrotic myocardium
during the first week after the initial 24 to 48 hours; 3,
the stage of rapid disappearance of the damaged muscle
cells, replacement of polymorphonuclear cells by mono-
nuclears, and new vascularization of the infarct in the
second week; 4, the laying down of the scar with the
beginning of the appearance of collagen in the third and
fourth weeks; and 5, the completely healed scar with
much collagen after 2 or 3 months]. An attempt to
define early infarct necrosis was afterwards performed
by Lodge-Patch [33] who focused on the character of the
cellular exudate as the most valuable feature in estimating
the age of a young infarct. The results constitute im-
portant findings concerning morphological changes and
chronological organization of myocardial infarct. Nuclear
changes in muscle fibers, necrosis and phagocytosis of
muscle, interstitial edema, neutrophils and polimorpho-
nuclears infiltration were found to be a typical pattern at a
time of 6–8 hours from the onset of acute symptoms [33].
These findings suggested that the age of a cardiac infarct
could be told from its histological appearances. However,
myocardial infarcts could not be accurately dated before
6–8 hours from the onset.
More recently, the first histological change, visible
within 10 minutes of onset, has been recognized to be the
intense hypereosinophilia of the hypercontracted myocar-
dial cells with rhexis of the myofibrillar apparatus into
cross-fiber, anomalous, and irregular pathological bands,
formed by segments of hypercontracted sarcomeres with
scalloped sarcolemma [20,34]. The lesion is unrelated to
ischemia. Its presence in acute coronary syndromes is
probably due to catecholamines released within the myo-
cardium as a reflex response [35] to regional asynergy of
the infarcted or perinfarcted zone, a hypothesis that is
supported by the abolishment of contraction bands and
ventricular fibrillation with beta-blocking agents in experi-
mental myocardial infarction and in reperfusion necrosis
[36]. They may trigger catecholamine myotoxicity linked
with ventricular fibrillation and acting through free radicalmediated lipid peroxidation with intramyocellular Ca2+
influx. Contrary to the general opinion that excess cat-
echolamines produce cardiotoxicity mainly through
binding to adrenoceptors, there is increasing evidence
that catecholamine-induced deleterious actions may also
occur through oxidative mechanisms [37,38], which un-
doubtedly occur during myocardial reperfusion after is-
chemia [17]. Interstitial edema and wavy fibers have been
also described [39] in very early infarct but these findings
are very unspecific [21]. No pathognomonic histological
sign is visible within 6 to 8 hours of survival after onset
when PMN infiltration starts. Consequently, despite several
attempts, no suitable histological criteria have materialized
into forensic practice.
Conclusions
We agree that “optimal assessment of cardiac remodeling
in myocardial infarction requires a wide range of functional,
molecular, histological, and proteomic investigations.
Understanding the temporal window of each cellular
and molecular response is critical for designing studies
exploring the mechanisms of repair and remodeling of the
infarcted heart” [2]. An approach based on the pathophy-
siochemistry of myocardial infarction may be useful to aid
or support “traditional” pathomorphological observations
[40]. Essential markers (i.e. IL-15, MCP-1) are suitable in-
dicators of myocardial response to ischemic insult involv-
ing very early phase reaction (inflammatory response and
cytokine release). The histological age determination of
myocardial infarction is an important task of forensic
medicine and requires thorough knowledge of the general
and specific pathology of myocardial infarction. So, we
need to investigate the pathology of myocardial infarction
as a cause of sudden cardiovascular death. Chronological
evaluation needs the analysis of parameters within a histo-
logical specimen such as any measurement of the number
and size of cellular expressions/modifications. Sometimes,
we need to judge the medical practice in the cases of in-
hospital myocardial infarction among patients who were
treated for other diseases and to determine the causal rela-
tionship with myocardial infarction as cause of death. In
the very near future, proteomics may help clinicians and
pathologists to better understand mechanisms related to
cardiac repair and remodeling and provide targets for
future therapies.
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